|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2000-12-21
|
|
pubmed:abstractText |
To evaluate the efficacy and tolerability of rabeprazole 10 mg and 20 mg versus placebo for the prevention of endoscopically demonstrable relapse in patients previously diagnosed with erosive or ulcerative gastro-oesophageal reflux disease (GORD) who had no oesophageal erosions or ulcerations at study entry. The study also assessed the effectiveness of rabeprazole in preventing GORD symptom recurrence and reductions in quality of life.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0954-691X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
889-97
|
|
pubmed:dateRevised |
2009-10-16
|
|
pubmed:meshHeading |
pubmed-meshheading:10958216-2-Pyridinylmethylsulfinylbenzimidazoles,
pubmed-meshheading:10958216-Adult,
pubmed-meshheading:10958216-Aged,
pubmed-meshheading:10958216-Analysis of Variance,
pubmed-meshheading:10958216-Benzimidazoles,
pubmed-meshheading:10958216-Dose-Response Relationship, Drug,
pubmed-meshheading:10958216-Double-Blind Method,
pubmed-meshheading:10958216-Enzyme Inhibitors,
pubmed-meshheading:10958216-Esophagitis,
pubmed-meshheading:10958216-Esophagoscopy,
pubmed-meshheading:10958216-Female,
pubmed-meshheading:10958216-Follow-Up Studies,
pubmed-meshheading:10958216-Gastroesophageal Reflux,
pubmed-meshheading:10958216-Humans,
pubmed-meshheading:10958216-Male,
pubmed-meshheading:10958216-Middle Aged,
pubmed-meshheading:10958216-Omeprazole,
pubmed-meshheading:10958216-Probability,
pubmed-meshheading:10958216-Recurrence,
pubmed-meshheading:10958216-Statistics, Nonparametric,
pubmed-meshheading:10958216-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Rabeprazole for the prevention of recurrent erosive or ulcerative gastro-oesophageal reflux disease. Rabeprazole Study Group.
|
|
pubmed:affiliation |
Center for Medical Research, Manchester, CT, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
